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The purpose of this study was to determine whether
adenosine or the adenosine deaminase-resistant ana-
logue, N6-R.l-phenyl-2-propyladenosine (RPIA), could
slowthe rate of spontaneous ventricular tachycardia oc-
curring 24 hours after left anterior descending coronary
artery occlusion. Chloralose-anesthetized, open chestdogs
(n = 25) with ventricular tachycardia were studied. The
left anterior descending artery was cannulated distally.
Intracoronary infusions of adenosine, 10- 7 to 10- 5 M,
did not alter the rate of ventricular tachycardia. Ven-
tricular tachycardia slowed by 4.6% with adenosine,
10- 4 M. RPIA, 10-6 to 10- 4 M, produced a concentra-
tion-dependent decrease in the rate of ventricular tachy-
cardia when injected into the left anterior descending
coronary artery. This effect of RPIA was reversed by
Since its effects on sinoatrial and atrioventricular (AV) node
function were first described by Drury and Szent-Gyorgyi
(I), numerous studies have evaluated the cardiac electro-
physiologic actions of adenosine. Adenosine depresses nor-
mal automaticity in Purkinje fibers in vitro (2,3), in isolated
ventricular preparations (4) and in vivo (5). In addition,
adenosine antagonizes the action of beta-adrenergic agonists
to increase automaticity (3,6). Because adenosine is released
by myocardial cells during conditions of hypoxia or isch-
emia (7) and in response to sympathetic neural stimulation
(8), endogenous adenosine may playa role in suppressing
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the adenosine antagonist aminophylline, 10- 5 M. After
bilateral stellate ganglionectomy, RPIA, 10- 5 M, did
not, but metoprolol, 0.5 mg, did slow ventricular tachy-
cardia after intracoronary injection. However, RPIA,
10- 5 M, produced a 43% decrease in the increment in
ventricular tachycardia occurring during sympathetic
neural stimulation.
Therefore, when injected into the left anterior de-
scending artery, adenosine, 10- 4 M, and RPIA, 10- 6 to
10- 4 M, decrease the rate of ventricular tachycardia in
24 hour old myocardial infarction. Furthermore, this
decrease in the rate of ventricular tachycardia is the
result of prejunctional sympathetic antagonism.
(J Am Coil Cardiol 1987;10:399-405)
ischemia or catecholamine-mediated ventricular arrhyth-
mias, or both.
Recently, Rosen et al. (3) demonstrated that adenosine
did not alter the automatic rate of Purkinje fibers obtained
from infarct areas 24 hours after left anterior descending
coronary artery occlusion in the dog, either before or during
exposure to epinephrine. These results suggested that aden-
osine would not directly modify the rate of the spontaneous
ventricular tachycardia that occurs over a similar time course
after myocardial infarction (9). However, this arrhythmia,
which originates in surviving subendocardial Purkinje fibers
(10-15), slows significantly after stellate ganglionectomy
(16). Because adenosine is a potent inhibitor of norepi-
nephrine release by peripheral and cardiac sympathetic nerves
(17- 21), we sought to determine whether adenosine or an
adenosine analogue would slow the rate of this ventricular
tachycardia. If such an effect could be demonstrated, we
wished to determine whether prejunctional or postjunctional
antagonism of sympathetic influences was responsible.
Methods
Experimental preparation. Mongrel dogs of either sex
weighing 21.8 ± 0.9 kg (n = 25) were anesthetized with
droperidol, 60 mg, fentanyl, 1.2 mg, and pentobarbital so-
0735-1097/87/$3.50
400 CONSTANTIN AND MARTINS
ADENOSINE AND VENTRICULAR TACHYCARDIA
JACC Vol. 10, No.2
August 1987:399--405
dium 15 mg/kg, and mechanically ventilated. The heart was
exposed through a left thoracotomy. The proximal left an-
terior descending coronary artery was bluntly dissected within
1 em from the tip of the atrial appendage and proximal to
the last major diagonal branch. A 20 gauge needle was
placed along the artery and a 2-0 silk ligature was tied around
the vessel and the needle. The needle was then withdrawn,
resulting in a coronary stenosis that was maintained for 20
minutes. The vessel was then permanently occluded by an-
other ligature. The chest was closed and the animal allowed
to recover. Twenty-four hours later two simultaneous sur-
face electrocardiographic (ECG) recordings (leads II and
either VsR or V6) were made in the surviving dogs at a
paper speed of 25 mm/s from 1 to 3 minutes. Each was
then anesthetized with alpha-chloralose, 100 mg/kg. Ad-
ditional bolus injections of chloralose were administered
throughout the experiments as needed to maintain anes-
thesia. If such were required, a period of time (usually 20
minutes) was allowed to elapse after each bolus to ensure
that all recorded values had returned to control before pro-
ceeding with any experimental interventions. The trachea
was intubated and the animal was ventilated with a volume
cycled respirator with air enriched with oxygen (2 li-
ters/min). Tidal volume was adjusted to maintain arterial
partial pressure of carbon dioxide (Pco-) in the normal range.
Sodium bicarbonate was administered as needed to reverse
the acidosis produced by chloralose anesthesia (22).
The sternum was split and the pericardium was incised
and sutured to the sternal incision to support the heart.
Temperature was maintained at 38.6 ± 0.3°C by means of
a plastic sheet placed over the incision and adjustment of
the distance of the operating table lamp to the heart. Tem-
perature was measured by a temperature probe positioned
on the epicardial surface of the heart. To remove vagal
reflexes, all animals underwent bilateral vagotomy by li-
gation and section of the midcervical vagi. To maximize
cardiac sympathetic efferent activity, bilateral carotid sinus
denervation was performed by isolating, ligating and sec-
tioning the internal carotid arteries together with their sur-
rounding neural structures. The femoral vein was cannulated
for systemic administration of drugs and patency was main-
tained by the slow infusion of 0.9% sodium chloride. The
femoral artery was incised and a fluid-filled catheter was
advanced into the aorta and connected to a pressure trans-
ducer (Statham P32db) for continuous measurement and
recording of mean arterial pressure. Mean pressures were
measured by electrical filtering.
Coronary artery cannulation. To avoid systemic ef-
fects, drugs were administered at pressures less than sys-
temic into the left anterior descending coronary artery (23)
distal to the ligature in all animals. To do this, a small
incision was made in the artery immediately distal to the
ligature and a 1.5 inch (3.81 ern), 22 gauge Teflon catheter
was passed through the incision into the vessel. This was
secured with a ligature tied around the vessel just distal to
the incision. Continuous pressure recordings from the intra-
coronary catheter (Fig. 1) were made by means of a pressure
transducer connected to the catheter by plastic tubing filled
with 0.9% sodium chloride solution containing 100 units of
heparinllOO ml. Catheter patency was maintained with pe-
riodic injections of the same solution given through an ac-
cess port built into the connecting tubing. The catheter was
aspirated periodically to confirm free flow of blood and to
remove drugs from the system.
Methylene blue and microsphere injections. To ex-
clude the no-reflow phenomenon (24) as a cause of failure
of drugs to alter ventricular tachycardia rate, 2 ml of meth-
ylene blue or 2 mCi of cerium-141-labeled microspheres
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Figure 1. Recordings during ventric-
ular tachycardia from one dog. Sur-
face electrocardiographic (ECG) leads
II and VsR, atrial (A eg) and ventric-
ular (V eg) electrograms,a tachometer
(Tach) tracing and aortic and coronary
artery (Cor) pressures are recorded si-
multaneously. The amplitude of the
tachometer tracing is directly related
to ventricular tachycardia cycle length.
I ml of the adenosineanalogue N6-R-
l-phenyl-z-propyladenosine (RPIA),
1O-5M, is injected into the coronary
artery and followed by I ml of saline
solution. Thirty-five seconds after sa-
line injection, ventricular tachycardia
(cycle length 316 ms) abruptly ter-
minates and is replaced bysinusrhythm
(cycle length 385 ms). After approx-
imately 15 seconds, ventriculartachy-
cardia returns at a cycle length of 411
ms.
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(15 p.m in diameter) was injected into the left anterior de-
scending artery at the completion of each experiment. We
have previously shown that microspheres injected into this
artery can be subsequently identified in the subendocardium
at the site of origin of ventricular tachycardia (23).
After the animals were sacrificed, the heart was excised.
In those receiving methylene blue, the heart was immedi-
ately sectioned and examined for subendocardial staining
by the dye. In those receiving microspheres, the heart was
fixed in formalin before sectioning. Autoradiograms were
then made of the slices.
In some animals in which drugs had no effect on ven-
tricular tachycardia, methylene blue failed to stain or mi-
crospheres did not localize in the subendocardium. Because
the methylene blue/microsphere data suggested that no-re-
flow was responsible for the absence of drug effect, data
from these animals were discarded and are not considered
in this report. Data from animals in which drugs failed to
alter ventricular tachycardia rate, but in which methylene
blue stained or microspheres localized in the subendocar-
dium were included in the analysis.
Electrophysiologic measurements. Surface ECGs were
recorded in the anesthetized state using limb lead II and
VsR. After the chest was opened, the sinus node was clamped
and overdrive atrial pacing was performed at a cycle length
of 300 ms using a bipolar hook electrode attached to the
right atrial appendage. Pacing stimuli were delivered from
a programmable stimulator with a constant current output
at four times diastolic threshold with pulses of 2 ms duration.
Atrial electrograms were recorded using a bipolar electrode
attached to the right atrial appendage. A local ventricular
electrogram was also recorded through a pair of Teflon-
coated stainless steel wires inserted into the normal zone in
the posterior left ventricle. Electrograms were amplified and
filtered from 40 to 500 Hz and recorded on an oscillographic
recorder.
Cessation of atrial drive resulted in the appearance of
spontaneous ventricular tachycardia. Ventricular tachycar-
dia was defined as a wide complex rhythm of rate > 100
beats/min in the presence of AV dissociation. Rate of ven-
tricular tachycardia was determined by counting the number
of complexes present over 30 seconds and multiplying by
2. Rates were counted for 15 seconds on either side of the
peak response, which typically occurred within 5 minutes
after drug injection. Changes in rate of ventricular tachy-
cardia were also readily apparent on a beat to beat basis by
scanning a tachometer recording triggered by the normal
zone ventricular electrogram. Changes in the height of a
ramp recording were directly proportional to changes in
cycle length of the ventricular rhythm (Fig. 1).
Experimental protocols. Twenty-five dogs were sub-
jected to one or more of the following protocols. Nine dogs
were given one or more infusions of adenosine, 10- 7 to
10 -- 4 M, into the left anterior descending coronary artery
and the effects on ventricular tachycardia rate and mean
aortic pressure were recorded. Adenosine was administered
as a continuous infusion over 5 minutes because of its rapid
inactivation in the myocardium (7). The infusion rate (3 to
6 mllmin) was adjusted to maintain intracoronary pressure
during drug administration at or below aortic pressure. This
was done to prevent spillover of adenosine into the systemic
circulation, which could result in undesired hemodynamic
effects. Mean aortic pressure was measured during over-
drive atrial pacing at a cycle length of 300 ms to correct
for the effects of drug-induced changes in rate of ventricular
tachycardia. Values were allowed to return to control before
proceeding to the next higher concentration.
Ten dogs were given one or more intracoronary injections
of the adenosine deaminase resistant adenosine analogue,
N6-R-l-phenyl-2-propyladenosine (RPIA), 10- 7 to 10-4 M,
and the effects on ventricular rate and mean aortic pressure
were assessed (RPIA was generously supplied by R. A.
Olsson, MD, University of South Florida Medical Center,
Tampa, Florida). Because of its anticipated longer duration
of action and the potential for systemic hemodynamic ef-
fects, RPIA was administered as a 1 ml bolus. The volume
of the cannula from the injection port to the site of insertion
of the coronary cannula equaled 1 ml. Therefore, each in-
jection of RPIA was followed by a 1 ml injection of 0.9%
sodium chloride. When the rate of ventricular tachycardia
was altered, a period of time sufficient to allow the rate to
return to the control value was allowed to elapse before
injection of the next higher dose.
To determine if the effect of RPIA on the rate of ven-
tricular tachycardia was indeed due to its interaction with
adenosine receptors, in six dogs, 1 ml of the adenosine
antagonist aminophylline (17-19), 10- 5 M, was injected
into the left anterior descending artery after giving RPIA,
10- 4 M. In eight dogs, the effects of RPIA, 10- 5 or 10- 4
M, were studied after pretreatment with 1 ml of amino-
phylline.
To ascertain whether the effect of RPIA on the rate of
ventricular tachycardia was due to sympathetic antagonism,
we examined the effect of RPIA, 10- 5 M, after withdrawal
of sympathetic neural influence in five dogs. Cardiac sym-
pathectomy was performed by isolation of both the right
and the left stellate ganglia (25). We also measured the
extent of inhibition by RPIA of the increase in the rate of
ventricular tachycardia induced by sympathetic neural stim-
ulation. Sympathetic stimulation was performed as follows.
The anterior ansae were gently cleared of surrounding adi-
pose and vascular tissue, and suspended in stainless steel
bipolar hook electrodes. Stimulation was performed with
the most medial electrode acting as cathode, using a stimulus
intensity just above threshold (4 to 10 V), stimulus duration
of 4 ms and frequency of 8 Hz. We also injected metoprolol,
0.5 mg, into the left anterior descending coronary artery in
five dogs after bilateral stellate ganglionectomy to determine
402 CONSTANTIN AND MARTINS
ADENOSINE AND VENTRICULAR TACHYCARDIA
JACC Vol. 10. No.2
August 1987:399-405
;( I I ! I
RPIA (M)
Control Control Control Control
10-' 10-' 10-; 10-'
~'\j\
lSEM
.. pe 0.05 vs Control t
t p- 0.01 vs Control
n=9n=9n=8
190
170
c
EQ3
.., 150
er
f-
>
130
whether the ventricular tachycardia was influenced by cir-
culating catecholamines. These experiments allowed us to
determine whether sympathetic antagonism by RPIA oc-
curred at the prejunctional or postjunctional level or both.
Carotid sinus denervation was not performed in animals
undergoing stellate ganglionectomy. In 10 dogs, I ml in-
jections of 0.9% sodium chloride given into the left anterior
descending artery served as an experimental control.
Statistical analysis. The data are expressed as mean
values ± SE. The comparison within groups was performed
by Student's t test or analysis of variance with Duncan's
multiple comparison technique as appropriate (26).
Results
In the conscious state before study and after chloralose
anesthesia, all surviving animals demonstrated spontaneous
ventricular tachycardia (Fig. 1). As we have shown previ-
ously (23), intracoronary injections of 0.9% sodium chloride
did not alter the rate of ventricular tachycardia (from 163
± 7.1 to 165 ± 7.4).
Effects ofadenosine. At a concentration of!0 -7 to 10- 5
M, adenosine did not slow ventricular tachycardia (Fig. 2).
Only at 10- 4 M was a decrease of 4.6% observed in the
rate of ventricular tachycardia. No change in mean aortic
pressure occurred during infusion of adenosine, even at
10- 4 M.
Effects of N6-R-l-phenyl-2-propyladenosine (RPIA).
Beginning at 10- 6 M, RPIA slowed ventricular tachycardia
in a concentration-dependent manner in 10 dogs (Fig. 3).
The onset of effect typically occurred rapidly, within I to
2 minutes after injection (Fig. I). RPIA did not consistently
alter mean aortic pressure during overdrive atrial pacing
(Fig. 4).
Effects of aminophylline. When injected into the left
anterior descending coronary artery in six dogs, amino-
Figure 3. RPIA, 10- 6 to 10- 4 M, injected into the left anterior
descending coronary artery produces a concentration-dependent
decrease in ventricular tachycardia (VT) rate. RPIA = N6-R-1-
phenyl-2-propyladenosine.
phylline, 10- 5 M, produced an almost immediate return to
the control value after RPIA, 10- 4 M, had significantly
slowed the rate of ventricular tachycardia (Fig. 5). In eight
dogs, pretreatment with aminophylline blunted the decline
in the rate of ventricular tachycardia after administration of
RPIA, 10- 5 M (from 160 ± 13.4 to 150 ± 12.4, P >
0.10), or RPIA, 10-4 M (from 160 ± 7.7 to 144 ± 14.0,
P > 0.10). Alone, aminophylline, 10- 5 M, had no effect
on the rate of ventricular tachycardia (from 173 ± 5.7 to
175 ± 8.6).
Effect of RPIA after stellate ganglionectomy and after
sympathetic stimulation (Table 1). In five dogs, bilateral
stellate ganglionectomy was performed. Bilateral stimula-
tion of the anterior ansae increased the rate of ventricular
tachycardia by 30% and increased mean aortic pressure by
37% (from 67 ± 8.4 to 92 ± 14.3, P < 0.05). After
sympathetic stimulation and return of the rate of ventricular
tachycardia and mean aortic pressure to the control values,
Figure 2. Adenosine, 10- 7 to 10- 5 M, infused into the left an-
terior descending coronary artery fails to alter ventricular tachy-
cardia (VT) rate. Only at 10- 4 M is a decrease in ventricular
tachycardia rate observed.
190
Figure 4. N6-R-I-phenyl-2-propyladenosine (RPIA), 10-7 to 10-4
M, doesnotconsistently altermeanaorticpressure. Aorticpressure
was measured during overdrive atrial pacing at a cycle length of
300 ms.
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Figure5. N6-R-I-phenyl-2-propyladenosine (RPIA), 10-4 M, slows
ventricular tachycardia (VT). Aminophylline, 10-5 M, reverses
the effect of RPIA.
RPIA, 10- 5 M, was given into the left anterior descending
coronary artery. After stellate ganglionectomy, RPIA did
not change the rate of ventricular tachycardia or mean aortic
pressure (from 77 ± 6.5 to 76.0 ± 8.0).
Ten minutes after intracoronary injection ofRPIA, sym-
pathetic nerve stimulation was repeated. The rate of ven-
tricular tachycardia increased by 17%. This increment in
ventricular tachycardia rate was only 57% (p < 0.05) of
that seen during sympathetic stimulation before administra-
tion of RPIA. In three of the five animals, 2 to 3 ml of
blood was subsequently aspirated from the left anterior de-
scending artery. Thirty minutes later, sympathetic stimu-
lation was repeated, producing an increment in ventricular
tachycardia rate similar in magnitude to the control value.
In contrast to its effect on the rate of ventricular tachycardia
during sympathetic stimulation, RPIA did not alter the in-
crement in mean aortic pressure (37% before RPIA; 36%
after RPIA).
Effect of metoprolol after stellate ganglionectomy. In
five dogs, metoprolol, 0.5 mg, was given into the left an-
terior descending artery after bilateral stellectomy. Ventric-
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ular tachycardia rate slowed by 11% (from 176 ± 18.5 to
156 ± 15.5, p < 0.01).
Discussion
Our data demonstrate that after intracoronary adminis-
tration, the adenosine analogue N6-R-I-phenyl-2-propyl-
adenosine (RPIA), but not adenosine (except at high con-
centration), slows the rate of spontaneous ventricular
tachycardia occurring 24 hours after left anterior descending
coronary artery occlusion in the dog. Furthermore, this ef-
fect occurs as a result of prejunctional inhibition of cardiac
sympathetic nerves.
Effect of adenosine. No effect of adenosine was ob-
served until infusion of 10- 4 M solution, a concentration
of adenosine that may be achieved in the interstitium in vivo
during ischemia (27). Although the lack of effect at lower
concentrations might be attributed to the no-reflowphenom-
enon, this is unlikely because significant slowing was ob-
served after injection of RPIA. In addition, we have pre-
viously demonstrated (23) that metoprolol, only 0.5 mg,
when injected into the coronary artery, slows ventricular
tachycardia. Furthermore, animals in which no effect was
observed were excluded if intracoronary methylene blue
failed to stain or cerium-141-labeled microspheres failed to
localize in the subendocardium. Lack of adenosine effect
except at a high concentration was therefore not likely due
to no reflow but to rapid cellular uptake (7), perhaps by
vascular endothelium, or to rapid inactivation by adenosine
deaminase, might reach a high concentration in the necrotic
interstitium, or both. We have no data on the maximal
concentration of adenosine actually achieved at the target
site; however, it would appear to be significantly lower than
that infused, especially because in saline-perfused prepa-
rations 50% inhibitionof norepinephrinerelease occurs after
exposure to concentrations of 10 -;, to 10 5 M (17).
Effect of RPIA. Beginning at 10-6 M. the adenosine
analogue, RPIA, injected into the left anterior descending
coronary artery produced a concentration-dependent slow-
Table 1. Effect of RPIA After Stellate Ganglionectomy and After Sympathetic
Neural Stimulation
Dog
Ventricular Tachycardia Rate/Min
No. Control I SNS Control 2 RPIA SNS
1 144 240 148 148 192
2 170 202 178 180 196
3 128 146 134 136 140
4 184 226 166 170 202
5 243 316 231 248 302
Mean 173.8 226.0' 171.4 176.4 206.4t
SEM 19.9 27.6 16.7 19.5 26.3
*p < 0.01 versus control I; tp < 0.05 versus N6-R-I-phenyl-2-propy1adenosine (RPIA). RPIA, 10 'M,
does not change the ventricular tachycardia rate from the control value, but reduces the increment in rate
produced by sympathetic neural stimulation (SNS).
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ing of ventricular tachycardia. This effect was probably due
to adenosine receptor stimulation because it was rapidly
reversed or prevented by intracoronary injection of the aden-
osine antagonist aminophylline, in a concentration that alone
had no effect on rate. Although our data do not establish
the adenosine receptor subtype involved, the production of
an effect by RPIA at a low concentration suggests that the
effect was mediated by A I receptor stimulation (21). This
is consistent with other work (8,21) demonstrating that pre-
synaptic inhibition of norepinephrine release is mediated by
the AI receptor.
Site of action of RPIA. RPIA, 10- 5 M. slowed ven-
tricular tachycardia significantly before but not after stellate
ganglionectomy, suggesting that the effect On the rate of
ventricular tachycardia was not direct, but mediated by sym-
pathetic antagonism. Furthermore, RPIA, 10- 5 M. reduced
the increment in ventricular tachycardia rate in response to
sympathetic nerve stimulation by almost 50%. Although this
can be explained by a prejunctional or postjunctional mech-
anism, or both, the effect of intracoronary metoprolol sug-
gests a prejunctional site of action of RPIA based on the
following argument. Metoprolol slowed ventricular tachy-
cardia in the absence of sympathetic nerve stimulation, in-
dicating that postjunctional beta-adrenergic receptor stim-
ulation was still present after bilateral stellate ganglionectomy.
If the effect of RPIA occurred at the postjunctional level,
it would have slowed ventricular tachycardia after bilateral
stellate ganglionectomy even in the absence of sympathetic
nerve stimulation. Therefore, RPIA slowed ventricular
tachycardia by a prejunctional sympathetic antagonism.
Our data are in agreement with those of Rosen et al. (3),
who performed in vitro studies of abnormally automatic
Purkinje fibers 24 hours after left anterior descending artery
occlusion. They showed that adenosine did not alter the
automatic rate in the presence or absence of epinephrine.
However, their preparation did not allow an assessment of
a prejunctional sympathetic antagonism by adenosine.
Possible clinical relevance. Although we examined the
effect of adenosine and RPIA on one type of ventricular
tachycardia, the data suggest that adenosine can modulate
sympathetic influences. The latter may be arrhythmogenic
earlier or later than 24 hours after coronary artery occlusion
(28). If so, agents such as dipyridamole, which augment
(29), or theophylline, which antagonize, the anti-adrenergic
effect of adenosine may playa role in the genesis of clinical
ventricular arrhythmias.
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